NFKB1 and inflammatory bowel disease: NF-κB pathway is activated in colon tissues of mice treated with DSS, as evidenced by increased phosphorylation levels of IκB and IKK and NF-κB p65, indicating that the excessive activation of the NF-κB pathway is one of the most important causes of IBD [39].